Incorporating healthy habits in your daily life can help prevent heart disease, from choosing heart-healthy foods and ...

Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

Weight-loss jabs will be rolled out across the NHS for the first time in an effort to tackle obesity. Health officials have ...

WASHINGTON, Sept 24 (Reuters) - U.S. Federal Reserve Governor Michelle Bowman said on Tuesday key measures of inflation remain "uncomfortably above" the Fed's 2% target, warranting caution as the ...

A new cholesterol-lowering drug called Nexletol has shown promise in reducing the risk of heart attacks and other cardiovascular ... the treatment of high cholesterol and the prevention of heart ...

Investors able to earn 5% on “cash” without taking a whole lot of risk have been pretty unwilling ... even after the Fed’s big rate cut of 50 basis points last week. Back To Top ...

New research highlights increased stroke, heart attack, and heart failure risks in cancer survivors, especially those treated with chemotherapy. The secondary analysis of a randomized, double ...

Medscape Medical News, June 12, 2024 EASL Congress 2024 Tirzepatide Shows Improvements ... Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart disease risk, treat sleep apnea and address ...

but with a new Fed easing cycle comes renewed risk of a bubble in parts of the market, Bank of America strategist Michael Hartnett said. On Wednesday, the central bank cut the fed funds rate by 50 ...

Novo's US rival Eli Lilly's drug tirzepatide is also approved for weight loss in the EU. Tirzepatide has shown to cut heart failure risk by 38% in a trial of preserved ejection fraction and obesity ...